Zhenxing Liao

Identification of SCN5a p.C335R Variant in a Large Family with Dilated Cardiomyopathy and Conduction Disease

J. Haas, F. Sedaghat-Hamedani, E. Kayvanpour, 2021, International journal of molecular sciences.

A cellular model of Brugada syndrome with SCN10A variants using human-induced pluripotent stem cell-derived cardiomyocytes.

J. Utikal, T. Wieland, M. Borggrefe, 2019, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Effects of Antiarrhythmic Drugs on hERG Gating in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1

M. Borggrefe, I. Akin, I. El-Battrawy, 2021, Frontiers in Pharmacology.

Drug Testing in Human‐Induced Pluripotent Stem Cell–Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1

T. Wieland, M. Borggrefe, W. Zimmermann, 2019, Clinical pharmacology and therapeutics.

Nucleoside Diphosphate Kinase B Contributes to Arrhythmogenesis in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes from a Patient with Arrhythmogenic Right Ventricular Cardiomyopathy

T. Wieland, M. Borggrefe, I. Akin, 2020, Journal of clinical medicine.

Lipopolysaccharide Modifies Sodium Current Kinetics through ROS and PKC Signalling in Induced Pluripotent Stem-Derived Cardiomyocytes from Brugada Syndrome Patient

I. Akin, I. El-Battrawy, Xiaobo Zhou, 2022, Journal of cardiovascular development and disease.

Deciphering the pathogenic role of a variant with uncertain significance for short QT and Brugada syndromes using gene‐edited human‐induced pluripotent stem cell‐derived cardiomyocytes and preclinical drug screening

A. Hierlemann, A. Saguner, I. Akin, 2021, Clinical and translational medicine.

A Preclinical Study on Brugada Syndrome with a CACNB2 Variant Using Human Cardiomyocytes from Induced Pluripotent Stem Cells

N. Swamy, A. Saguner, I. Akin, 2022, International journal of molecular sciences.

Novel insights in the pathomechanism of Brugada syndrome and fever‐related type 1 ECG changes in a preclinical study using human‐induced pluripotent stem cell‐derived cardiomyocytes

I. Akin, I. El-Battrawy, L. Cyganek, 2023, Clinical and translational medicine.

Studying Brugada Syndrome With an SCN1B Variants in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes

J. Utikal, T. Wieland, M. Borggrefe, 2019, Front. Cell Dev. Biol..